Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Matilda Holm

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8453-3936; OpenAlex author ID A5084039109. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper

Papers 3

  1. Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. Co-author DOI 10.1158/0008-5472.can-22-1742↗
  2. Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma. Co-author DOI 10.1073/pnas.1920240117↗
  3. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival. Co-author DOI 10.1177/1010428320936410↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Caj H. Haglund · 2 shared papers, 2020 · strength 0.23
  2. Olivera Grbovic-Huezo · 2 shared papers, 2020–2022 · strength 0.22
  3. Kenneth L Pitter · 2 shared papers, 2020–2022 · strength 0.22
  4. Tuomas Tammela · 2 shared papers, 2020–2022 · strength 0.22
  5. Christine A. Iacobuzio–Donahue · 2 shared papers, 2020–2022 · strength 0.22
  6. Hanna E. Seppänen · 1 shared paper, 2020 · strength 0.13
  7. Mayank Saraswat · 1 shared paper, 2020 · strength 0.13
  8. Risto Renkonen · 1 shared paper, 2020 · strength 0.13
  9. Dana Pe'er · 1 shared paper, 2022 · strength 0.13
  10. Simon Joost · 1 shared paper, 2022 · strength 0.13
  11. Anupriya Singhal · 1 shared paper, 2022 · strength 0.13
  12. Suhasini Joshi · 1 shared paper, 2020 · strength 0.10
  13. Gökçe Aşkan · 1 shared paper, 2020 · strength 0.10
  14. Steven D Leach · 1 shared paper, 2020 · strength 0.10
  15. Rohit Chandwani · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.